Abstract
Current renal substitution therapy with hemodialysis or hemofiltration has been the only successful long-term ex vivo organ substitution therapy to date. Although this approach is life sustaining, it is still unacceptably suboptimal with poor clinical outcomes of patients with either chronic end-stage renal disease or acute renal failure. This current therapy utilizes synthetic membranes to substitute for the small solute clearance function of the renal glomerulus but does not replace the transport, metabolic, and endocrinologic functions of the tubular cells. The addition of tubule cell replacement therapy in a tissue-engineered bioartificial kidney comprising both biologic and synthetic components will likely optimize renal replacement to improve clinical outcomes. This report demonstrates that the combination of a synthetic hemofiltration device and a renal tubule cell therapy device containing porcine renal tubule cells in an extracorporeal perfusion circuit successfully replaces filtration, transport, metabolic, and endocrinologic functions of the kidney in acutely uremic dogs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gage, F.H. Cell therapy. Nature 392, 518– 524 (1998).
Langer, R. & Vacanti, J.P. Tissue engineering. Science 260, 920–926 (1993).
Watanabe, F.D. et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 225, 484–491 (1997).
Maki, T. et al. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas. Diabetes 45, 342–347 (1996).
Humes, H.D., MacKay, S.M., Funke, A.J. & Buffington, D.A. Acute renal failure: growth factors, cell therapy, gene therapy. Proc. Assoc. Am. Physicians 109, 547– 557 (1997).
Yagi, N. & Paganini E.P. Acute dialysis and continuous renal replacement: the emergence of new technology involving the nephrologist in the intensive care setting. Semin. Nephrol. 17, 306–320 (1997).
Mehta, R.L. Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin. Nephrol. 14, 64–82 (1994).
Zarowitz, B.J., Anandan, J.V., Dumler, F., Jayashankar, J. & Levin, N. Continuous arteriovenous hemofiltration of aminoglycoside antibiotics in critically ill patients. J. Clin. Pharm.. 26, 686–689 (1986).
Excerpts from United States Renal Data System. Annual Data Report. Am.. J. Kidney Dis. 32(suppl 1), 569–580 (1998).
Humes, H.D. Acute renal failure: prevailing challenges and prospects for the future. Kidney Int. 48, S-26–S-32 (1995).
Humes, H.D., MacKay, S.M., Funke, A.J. & Buffington D.A. The bioartificial renal tubule assist device to enhance CRRT in acute renal failure. Am. J. Kidney Dis. 30, S28– S31 (1997).
MacKay, S.M., Funke, A.J., Buffington, D.A. & Humes, H.D. Tissue engineering of a bioartificial renal tubule. ASAIO J. 44, 179–183 (1998).
Humes, H.D., MacKay, S.M., Funke, A.J. & Buffington, D.A. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int. (In press).
Nikolovski, J., Gulari, E. & Humes, H.D. Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant. (In press).
Bidlack, J.M. & Lockshin, R.A. Evolution of LDH isozymes during programmed cell death. Comp. Biochem. Physiol. 55, 161–166 (1976).
Knox, F.G., Merz, J.I, Burnett, J.C. Jr & Haramati, A. Role of hydrostatic and oncotic pressures in renal sodium reabsorption. Circ. Res. 52, 491–500 (1983).
Berry, C.A., Ives, H.E. & Rector, F.C. Jr. in The Kidney 5th edn (ed. Brenner, B.M.) 334–370 (W.B. Saunders, Philadelphia, 1996).
Pitts, R.F. The renal regulation of acid base balance with special reference to the mechanism for acidifying the urine. I and II. Science 102,49–51, 81–85 (1945).
Schoolwerth, A.C. Regulation of renal ammoniagenesis in metabolic acidosis. Kidney Int. 40, 961–973 (1991).
Curthoys, N.P. Role of γ-glutamyltranspeptidase in the renal metabolism of glutathione. Miner. Electrolyte Metab. 9, 236– 245 (1983).
Lehmann, J. Jr & Gray, R.W. in Renal Endocrinology . (ed. Dunn, M.J.) 114–141 (Williams & Wilkins, Baltimore, MD, 1983).
Humes, H.D. in Biomedical Engineering Handbook. (ed. Bronzino, J.) 1807– 1824 (CRC, 1995).
Humes, H.D. & Cieslinski, D.A. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp. Cell Res. 201, 8– 15 (1992).
Humes, H.D., Krauss, J.C., Cieslinski, D.A. & Funke, A.J. Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus. Am. J. Physiol. 271, F42–F49 (1996).
Timpl, R. et al. Laminin—a glycoprotein from basement membranes. J. Biol. Chem. 254, 9933–9937 (1979).
O'Neil J.J. et al. Immunoprotection provided by the bioartificial pancreas in a xenogeneic host. Trans. Proc. 29, 2116– 2117 (1997).
Pitts, R.F. Renal excretion of acid. Fed. Proc. 7, 418 –426 (1948).
Cozzi, E. & White, D. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1, 965–966 (1995).
Acknowledgements
This work was supported by National Institutes of Health Grants DK-39255, DK-48175, and DK-50539, the VA Research Service, and Nephros Therapeutics. The expert technical assistance of Annie Browning and Anand Gupte, along with the excellent secretarial support of Donna Hall, is appreciated
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Humes, H., Buffington, D., MacKay, S. et al. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 17, 451–455 (1999). https://doi.org/10.1038/8626
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/8626
This article is cited by
-
Development of a hollow fibre-based renal module for active transport studies
Journal of Artificial Organs (2021)
-
A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations
Renal Replacement Therapy (2019)
-
Urine-derived cells for human cell therapy
Stem Cell Research & Therapy (2018)
-
Bioengineering in renal transplantation: technological advances and novel options
Pediatric Nephrology (2018)
-
Current Bioengineering and Regenerative Strategies for the Generation of Kidney Grafts on Demand
Current Urology Reports (2017)